Monographie - Urokinase - Stabilis 4.0

Viimeisin päivitys :
05/12/2025

Trombolyytit

Urokinase

Injektioneste

Stabilius liuoksessa

Stabilius seoksissa

Tekijät, jotka vaikuttavat stabiliuteen

Yhteensopivuus

Antotapa

Viitteet

pdf

Kauppanimi

Kauppanimi

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Abbokinase	Itävalta, Yhdysvallat
Actosolv	Belgia, Luxemburg, Ranska
Angikinase	Egypti
Corase	Saksa
Dukinase	Intia
KD Unase	Intia
Medacinase	Hollanti
Rheotromb	Unkari
Syner-Kinase	Iso-Britannia
Ukidan	Kreikka
Urochinasi	Italia
Urokinase	Espanja, Hollanti, Itävalta, Luxemburg, Malesia, New Zealand, Saksa, Suomi, Sveitsi
Uroquinasa	Chile

Viitteet

Injektioneste

Viitteet : Urokinase

	tyyppi	julkaisu
375	Lehti	Patel JP, Tran LT, Sinai WJ, Carr LJ. Activity of urokinase diluted in 0.9% sodium chloride injection or 5% dextrose injection and stored in glass or plastic syringes. Am J Hosp Pharm 1991 ; 48: 1511-1514.
1061	Lehti	Rhoney DH, Coplin WM, Zaran FK, Brish LK, Weingarten CM. Urokinase after freezing : Implications for thrombolysis in intraventricular hemorrhage. Am J Health-Syst Pharm 1999 ; 56: 2047-2051.
1394	Lehti	Zimmermann R, Sch?ffel G, Harenberg J. Urokinase therapy: dose reduction by administration in plastic material. Thromb Haemost 1981 ; 45: 296.
1395	Lehti	Toki N, Sumi H. Glass adsorption of highly purified urokinase. Thromb Haemost 1980 ; 43: 67.
1941	Lehti	Dedrick SC, Ramirez-Rico J. Potency and stability of frozen urokinase solutions in syringes. Am J Health-Syst Pharm 2004 ; 61: 1586-1589.
2050	Lehti	Kohles JD, Weld M, Asa?d H, Gunning P, Reid Sterrett J, Debari VA. Stability of reconstituted urokinase solutions. Current Ther Res 2000 ; 61: 1-6
5057	Laboratorio	ACTOSOLV 600 000 UI, poudre pour solution injectable/pour perfusion - Résumé des caractéristiques du produit. EUMEDICA PHARMACEUTICALS GMBH 2019

Mentions Légales